GÜLAY ERMAN

Dr. GÜLAY ERMAN

orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2015 in Cytotherapy
Verified
Journal Article
Closed access
EEEsra Emre
Esra Emre
NYNurşen Yüksel
Nurşen Yüksel
GDGökhan DURUKSU
Gökhan DURUKSU
DPDilara Pirhan
Dilara Pirhan
CSCansu Subaşi
Cansu Subaşi
EKErdal Karaöz
Erdal Karaöz

1 January 2016 in Turkish Journal of Hematology
Verified
Journal Article
Open access
EKErdal Karaöz
Erdal Karaöz
PDPınar Çetinalp Demircan
Pınar Çetinalp Demircan
GEGÜLAY ERMAN
GÜLAY ERMAN
EGEda Güngörürler
Eda Güngörürler
ASAyla Eker Sarıboyacı
Ayla Eker Sarıboyacı
Mesenchymal stem cells (MSCs), which possess immunosuppressive characteristics on induced T-cells, were shown to be applicable in prevention and treatment of graft-versus-host disease. However, knowledge of effective cell sources is still limited. In this study, MSCs from different human tissues, i.e. bone marrow (BM), Wharton's jelly (WJ), and adipose tissue, were isolated, and the immune suppression of stimulated T cells was analyzed comparatively. MSCs were co-cultured with phytohemagglutinin-induced T-cells with co-culture techniques with and without cell-to-cell contact. After co-culture for 24 and 96 h, the proliferation rate of T cells was estimated by carboxyfluorescein succinimidyl ester and apoptosis by annexin V/PI methods. Both T cells and MSCs were analyzed with respect to gene expressions by real-time polymerase chain reaction and their specific protein levels by ELISA. The results showed that all three MSC lines significantly suppressed T-cell proliferation; BM-MSCs were most effective. Similarly, T-cell apoptosis was induced most strongly by BM-MSCs in indirect culture. In T cells, the genes in NFkB and tumor necrosis factor pathways were silenced and the caspase pathway was induced after co-culture. These results were confirmed with the measurement of protein levels, like transforming growth factor β1, IL-6, interferon-γ, interleukin (IL)-2, and tumor necrosis factor-α. Additionally, IL-17A was detected in high levels in WJ-MSC co-cultures. We showed that IL-17A-producing Tregs are the key mediators in the treatment of graft-versus-host disease. BM-MSCs, which have been used in clinical applications for a while, showed the greatest immunosuppressive effect compared to other MSCs. However, a promising cell source could also be WJ, which is also effective in suppression with fewer ethical concerns. We described the molecular mechanism of WJ-MSCs in allogenic transplants for the first time.

21 September 2013 in Journal of Orthopaedic Research
Verified
Journal Article
Open access
PDF file
AAAdem Aydın
Adem Aydın
GDGökhan DURUKSU
Gökhan DURUKSU
GEGÜLAY ERMAN
GÜLAY ERMAN
CSCansu Subaşı
Cansu Subaşı
AAAyça Aksoy
Ayça Aksoy
EKErdal Karaöz
Erdal Karaöz
In this study, analysis and comprehensive comparison of neurogenic differentiation capacity of human bursal tissue‐derived‐stem cells (hBT‐SCs) was aimed with human bone marrow derived mesenchymal stem cells (hBM‐MSCs). hBT‐SCs was isolated from subacromial bursa tissue (n = 3) by collagen type‐II digestion. The expression of stem cell markers, differentiation capacity and telomerase activity were determined for both cell lines. The expression levels of neurogenic cell markers were compared consecutively. With respect to the surface marker profile, both cells display similar pluripotency phenotypes. Both cells successfully differentiated into osteo‐ and adipogenic cell lines. The immune staining of mesenchymal, stem cell and neurogenic markers gave positive reaction. The gene expression level for Tubb3, Nestin, Gfap, Map2, Nf‐h, and Nf‐l was higher in hBT‐SCs than hBM‐MSCs. The high level of neurotrophic factors, like Tenascin C, NGF, BDNF, VEGF, and CNTF might indicate their regeneration and maintenance capacity in damaged neural tissue. Besides they are alternative source for human mesenchymal stem cells, hBT‐SCs assess the possibility to use in clinical studies. © 2013 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 32:151–158, 2014.

4 July 2022 in World Journal of Microbiology and Biotechnology
Verified
Journal Article
Closed access
PDF file
HHHuseyin Hatipoglu
Huseyin Hatipoglu
GEGÜLAY ERMAN
GÜLAY ERMAN
HTHande Toptan
Hande Toptan
MKMehmet Koroglu
Mehmet Koroglu
MAMustafa Altindis
Mustafa Altindis

3 July 2011 in Cell Biochemistry and Function
Verified
Journal Article
Closed access
PDF file
MKMurat Kasap
Murat Kasap
EKErdal Karaoz
Erdal Karaoz
GAGürler Akpınar
Gürler Akpınar
AAAyca Aksoy
Ayca Aksoy
GEGÜLAY ERMAN
GÜLAY ERMAN

14 March 2025 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
EBElif Kale Bakir
Elif Kale Bakir
AOAsuman Deveci Ozkan
Asuman Deveci Ozkan
GEGÜLAY ERMAN
GÜLAY ERMAN
SISemih Isik
Semih Isik
Yonca Yuzugullu KarakusYonca Yuzugullu Karakus
Yonca Yuzugullu Karakus